Havn Life Archives

Psychedelics News

Havn Life

Press Releases

22 Jan 2021

Havn Life Sciences announces inclusion in first psychedelic Exchange Traded Fund

Havn Life is one of a select number of companies that are included in the new ETF Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

18 Jan 2021

Havn Life to support Canadian counterpart of Veterans’ organization Heroic Hearts

Havn Life to grow its partnership with the US-based veterans’ organization by funding and supporting the launch of its Canadian counterpart....

By Microdose

Press Releases

7 Jan 2021

Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

NOT FOR DISTRIBUTION TO U....

By Microdose

Press Releases

22 Dec 2020

Havn Life Sciences and Nesters Market, a leading Canadian retailer of Natural Health and Wellness Products, announce an authorized products listing

Nesters Market retail chain, will list and promote the full range of Havn Life’s natural health supplements across its stores in British Columbia in Q1 2021....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

17 Dec 2020

Havn Life Sciences provides update on retail strategy and product development

Havn Retail is on track for its Q1 2021 launch of its initial line of natural health supplements....

By Microdose

Press Releases

16 Dec 2020

Havn Life Sciences hits major milestone with research partner, Complex Biotech Discovery Ventures

Havn Research signs contract with CBDV, located at The University of British Columbia’s Vancouver campus, to begin Health Canada approved research to analyze psilocybin under Havn Life’s Section 56 exemption....

By Microdose

Press Releases

15 Dec 2020

Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

15 Dec 2020

Havn Life Sciences announces $5 million Bought Deal Financing

NOT FOR DISTRIBUTION TO U....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result